BELLUS is a Canada-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of refractory chronic cough disorders... Read more
BELLUS is a Canada-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of refractory chronic cough disorders... Read more
News
Jun 30, 2023
Pharmabiz
BELLUS Health: GSK completes acquisition of latestage biopharma company, BELLUS Health
Jun 30, 2023
Pharmaceutical Business Review
BELLUS Health: GSK acquires pharma firm Bellus Health for $2bn
Jun 29, 2023
MarketScreener
BELLUS Health: BELLUS Health Inc.(TSX:BLU) dropped from S&P Global BMI Index
Jun 28, 2023
MarketScreener
BELLUS Health: BELLUS Health : MATERIAL CHANGE REPORT - Form 6-K
Jun 19, 2023
Proactive Investors
BELLUS Health: Bellus Health shareholders agree to US$2B GSK takeover
Jun 16, 2023
MarketScreener
BELLUS Health: BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
May 16, 2023
Acrofan
BELLUS Health: BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK Acquisition
May 12, 2023
MarketScreener
BELLUS Health: BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
May 12, 2023
Benzinga
BELLUS Health: BELLUS Health: Q1 Earnings Insights
Apr 28, 2023
IndiaMedToday
BELLUS Health: GSK in agreement to acquire late-stage biopharma company BELLUS Health
BELLUS Health Competitors
1
2
3
4
5
6
7
8
9
10